Xun Li

Title: Xun Li: Innovator in Breast Cancer Treatment

Introduction

Xun Li is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of breast cancer. His innovative approach has the potential to change the landscape of cancer treatment.

Latest Patents

Xun Li holds a patent for the use of mitoxantrone preparation in the preparation of a drug for diagnosing and treating breast cancer. This patent outlines the use of mitoxantrone and/or a pharmaceutically acceptable salt in the preparation of a lymphatic tracer for diseases associated with breast resection. The preparation has shown no local or systemic toxic and side effects after local injection, indicating good tolerance, effectiveness, and safety. This innovation provides a new treatment idea for thoroughly curing breast cancer in patients.

Career Highlights

Throughout his career, Xun Li has worked with prominent companies in the pharmaceutical industry. He has been associated with Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd and Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in medical treatments and pharmaceuticals.

Collaborations

Xun Li has collaborated with notable professionals in his field, including Jun Liu and Zhanao Yang. These collaborations have fostered innovation and development in cancer treatment methodologies.

Conclusion

Xun Li's contributions to breast cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in medical science and offers hope for effective cancer therapies.